Markets & regulatory news

Pharma CEOs head to New York

Dispatches from BIO CEO 2015

Experts say industry interactions with US FDA improving

By Zachary Brennan

Though it’s difficult to quantify, industry experts told investors at the BIO CEO conference in New York on Monday that the US FDA-industry interactions are improving though there’s still some inconsistency between FDA leadership, division directors and...

US FDA seeks modest budget bump for FY2016

US FDA seeks modest budget bump for FY2016

By Zachary Brennan

The US Food and Drug Administration (FDA) is requesting a budget of $4.9bn for fiscal year (FY) 2016 – a 9% increase over the enacted budget for FY 2015. 

Biotec handles products between 25ºC and -196ºC. (Image: Andy Melton)

PCI company expands temp-controlled trial supply services

By Fiona BARRY

Biotec Services International, daughter company of clinical trial suppliers Packaging Coordinators Inc (PCI), has expanded its cold-chain storage and distribution capacity in response to client demand for a “one-stop shop”.

MHRA: Wockhardt non-compliance includes all APIs for EU market

MHRA: Wockhardt non-compliance includes all APIs for EU market

By Zachary Brennan

Following Wockhardt’s decision to cease supplying APIs to the EU market, the UK drug regulator MHRA (Medicines and Healthcare Products Regulatory Agency) has updated its statement of noncompliance to include all APIs made from the India-based manufacturer.

Without proper treatment, APIs in prescription medicines can pollute the water supply. (Image: Peter Dutton)

Drug disposal not our problem, industry tells Supreme Court

By Fiona BARRY

Industry groups PhRMA, BIO and GPhA are petitioning the Supreme Court to overturn a local law that requires pharma companies to cough up payment for safe disposal of medicines which make their way to one county.

Will ePRO prove successful in the years to come? Survey investigates

CROs plan to increase use of ePRO tech

By Zachary Brennan

CROs, as well as sponsors, are receptive to, and plan to increase their use of ePRO (electronic patient reported outcomes), according to a survey published Monday from the Tufts Center for the Study of Drug Development.

US FDA launches quality office

US FDA launches overarching Office of Pharmaceutical Quality

By Zachary Brennan

Industry won’t see much of an initial impact from the US FDA’s newly formed Office of Pharmaceutical Quality, though in a couple of years the agency will have more benchmarks and new technology to find and single out the worst manufacturers. 

Follow us

Products

View more

Webinars